Cargando…
Molecular identification of T-box transcription factor 6 and prognostic assessment in patients with congenital scoliosis: A single-center study
BACKGROUND: Congenital scoliosis (CS) is characterized by vertebral malformations. The precise etiology of CS is not fully defined. A compound inheritance of TBX6 was identified in 10% of patients with CS in Han Chinese and formed a distinguishable subtype named TBX6-associated congenital scoliosis...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403053/ https://www.ncbi.nlm.nih.gov/pubmed/36035411 http://dx.doi.org/10.3389/fmed.2022.941468 |
_version_ | 1784773284755144704 |
---|---|
author | Zhang, Wenyan Yao, Ziming Guo, Ruolan Li, Haichong Zhao, Shuang Li, Wei Zhang, Xuejun Hao, Chanjuan |
author_facet | Zhang, Wenyan Yao, Ziming Guo, Ruolan Li, Haichong Zhao, Shuang Li, Wei Zhang, Xuejun Hao, Chanjuan |
author_sort | Zhang, Wenyan |
collection | PubMed |
description | BACKGROUND: Congenital scoliosis (CS) is characterized by vertebral malformations. The precise etiology of CS is not fully defined. A compound inheritance of TBX6 was identified in 10% of patients with CS in Han Chinese and formed a distinguishable subtype named TBX6-associated congenital scoliosis (TACS). METHODS: To investigate the variants and risk haplotype of TBX6, we recruited 121 patients with CS at Beijing Children’s Hospital. We collected the clinical characteristics and surgical treatment options and followed their postoperative prognoses. RESULTS: Eight patients (6.6%) were molecularly diagnosed with TACS and carried the previously defined pathogenic TBX6 compound heterozygous variants. All the eight patients with TACS had the typical TACS clinical feature of hemivertebrae in the lower part of the spine. These patients received posterior hemivertebra resection combined with segmental fusion. Follow-ups revealed satisfactory correction without postoperative complications. CONCLUSION: We observed a 6.6% prevalence of TACS in our CS cohort. Follow-ups further highlighted that surgical treatment of hemivertebra resection combined with segmental fusion performed well with prognosis for patients with TACS. This could provide valuable information for CS individuals with compound heterozygosity in TBX6. |
format | Online Article Text |
id | pubmed-9403053 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94030532022-08-26 Molecular identification of T-box transcription factor 6 and prognostic assessment in patients with congenital scoliosis: A single-center study Zhang, Wenyan Yao, Ziming Guo, Ruolan Li, Haichong Zhao, Shuang Li, Wei Zhang, Xuejun Hao, Chanjuan Front Med (Lausanne) Medicine BACKGROUND: Congenital scoliosis (CS) is characterized by vertebral malformations. The precise etiology of CS is not fully defined. A compound inheritance of TBX6 was identified in 10% of patients with CS in Han Chinese and formed a distinguishable subtype named TBX6-associated congenital scoliosis (TACS). METHODS: To investigate the variants and risk haplotype of TBX6, we recruited 121 patients with CS at Beijing Children’s Hospital. We collected the clinical characteristics and surgical treatment options and followed their postoperative prognoses. RESULTS: Eight patients (6.6%) were molecularly diagnosed with TACS and carried the previously defined pathogenic TBX6 compound heterozygous variants. All the eight patients with TACS had the typical TACS clinical feature of hemivertebrae in the lower part of the spine. These patients received posterior hemivertebra resection combined with segmental fusion. Follow-ups revealed satisfactory correction without postoperative complications. CONCLUSION: We observed a 6.6% prevalence of TACS in our CS cohort. Follow-ups further highlighted that surgical treatment of hemivertebra resection combined with segmental fusion performed well with prognosis for patients with TACS. This could provide valuable information for CS individuals with compound heterozygosity in TBX6. Frontiers Media S.A. 2022-08-11 /pmc/articles/PMC9403053/ /pubmed/36035411 http://dx.doi.org/10.3389/fmed.2022.941468 Text en Copyright © 2022 Zhang, Yao, Guo, Li, Zhao, Li, Zhang and Hao. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Zhang, Wenyan Yao, Ziming Guo, Ruolan Li, Haichong Zhao, Shuang Li, Wei Zhang, Xuejun Hao, Chanjuan Molecular identification of T-box transcription factor 6 and prognostic assessment in patients with congenital scoliosis: A single-center study |
title | Molecular identification of T-box transcription factor 6 and prognostic assessment in patients with congenital scoliosis: A single-center study |
title_full | Molecular identification of T-box transcription factor 6 and prognostic assessment in patients with congenital scoliosis: A single-center study |
title_fullStr | Molecular identification of T-box transcription factor 6 and prognostic assessment in patients with congenital scoliosis: A single-center study |
title_full_unstemmed | Molecular identification of T-box transcription factor 6 and prognostic assessment in patients with congenital scoliosis: A single-center study |
title_short | Molecular identification of T-box transcription factor 6 and prognostic assessment in patients with congenital scoliosis: A single-center study |
title_sort | molecular identification of t-box transcription factor 6 and prognostic assessment in patients with congenital scoliosis: a single-center study |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403053/ https://www.ncbi.nlm.nih.gov/pubmed/36035411 http://dx.doi.org/10.3389/fmed.2022.941468 |
work_keys_str_mv | AT zhangwenyan molecularidentificationoftboxtranscriptionfactor6andprognosticassessmentinpatientswithcongenitalscoliosisasinglecenterstudy AT yaoziming molecularidentificationoftboxtranscriptionfactor6andprognosticassessmentinpatientswithcongenitalscoliosisasinglecenterstudy AT guoruolan molecularidentificationoftboxtranscriptionfactor6andprognosticassessmentinpatientswithcongenitalscoliosisasinglecenterstudy AT lihaichong molecularidentificationoftboxtranscriptionfactor6andprognosticassessmentinpatientswithcongenitalscoliosisasinglecenterstudy AT zhaoshuang molecularidentificationoftboxtranscriptionfactor6andprognosticassessmentinpatientswithcongenitalscoliosisasinglecenterstudy AT liwei molecularidentificationoftboxtranscriptionfactor6andprognosticassessmentinpatientswithcongenitalscoliosisasinglecenterstudy AT zhangxuejun molecularidentificationoftboxtranscriptionfactor6andprognosticassessmentinpatientswithcongenitalscoliosisasinglecenterstudy AT haochanjuan molecularidentificationoftboxtranscriptionfactor6andprognosticassessmentinpatientswithcongenitalscoliosisasinglecenterstudy |